Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Potter

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
RNA (New York, N.Y.)|November 18, 2018
Corrigendum: Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skippingGang Wu, Liying Fan, Michael N Edmonson, et al.
RNA (New York, N.Y.)|May 31, 2018
Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skippingGang Wu, Liying Fan, Michael N Edmonson, et al.
Journal of Medicinal Chemistry|March 24, 2007
Selective inhibition of carboxylesterases by isatins, indole-2,3-dionesJanice L Hyatt, Teri Moak, M Jason Hatfield, et al.
Molecular Pharmacology|March 18, 2005
The crystal structure of the complex of the anticancer prodrug 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica acetylcholinesterase provides a molecular explanation for its cholinergic actionMichal Harel, Janice L Hyatt, Boris Brumshtein, et al.
Molecular Pharmacology|December 15, 2006
Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compoundsRandy M Wadkins, Janice L Hyatt, Carol C Edwards, et al.
Nucleic Acids Research|March 14, 2014
Sudemycin E influences alternative splicing and changes chromatin modificationsPaolo Convertini, Manli Shen, Philip M Potter, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2005
Activation and antitumor activity of CPT-11 in plasma esterase-deficient miceChristopher L Morton, Lisa Iacono, Janice L Hyatt, et al.
Molecular Pharmacology|May 25, 2004
Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activityRandy M Wadkins, Janice L Hyatt, Kyoung Jin P Yoon, et al.
Chemico-Biological Interactions|November 1, 2005
Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11Janice L Hyatt, Lyudmila Tsurkan, Christopher L Morton, et al.
The Journal of Biological Chemistry|February 2, 2012
ATP-dependent mitochondrial porphyrin importer ABCB6 protects against phenylhydrazine toxicityDagny L Ulrich, John Lynch, Yao Wang, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
RNA (New York, N.Y.)|November 18, 2018
Corrigendum: Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skippingGang Wu, Liying Fan, Michael N Edmonson, et al.
RNA (New York, N.Y.)|May 31, 2018
Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skippingGang Wu, Liying Fan, Michael N Edmonson, et al.
Journal of Medicinal Chemistry|March 24, 2007
Selective inhibition of carboxylesterases by isatins, indole-2,3-dionesJanice L Hyatt, Teri Moak, M Jason Hatfield, et al.
Molecular Pharmacology|March 18, 2005
The crystal structure of the complex of the anticancer prodrug 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica acetylcholinesterase provides a molecular explanation for its cholinergic actionMichal Harel, Janice L Hyatt, Boris Brumshtein, et al.
Molecular Pharmacology|December 15, 2006
Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compoundsRandy M Wadkins, Janice L Hyatt, Carol C Edwards, et al.
Nucleic Acids Research|March 14, 2014
Sudemycin E influences alternative splicing and changes chromatin modificationsPaolo Convertini, Manli Shen, Philip M Potter, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2005
Activation and antitumor activity of CPT-11 in plasma esterase-deficient miceChristopher L Morton, Lisa Iacono, Janice L Hyatt, et al.
Molecular Pharmacology|May 25, 2004
Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activityRandy M Wadkins, Janice L Hyatt, Kyoung Jin P Yoon, et al.
Chemico-Biological Interactions|November 1, 2005
Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11Janice L Hyatt, Lyudmila Tsurkan, Christopher L Morton, et al.
The Journal of Biological Chemistry|February 2, 2012
ATP-dependent mitochondrial porphyrin importer ABCB6 protects against phenylhydrazine toxicityDagny L Ulrich, John Lynch, Yao Wang, et al.
Pageof 9